Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00358670
Status:
TERMINATED
Last Update Posted:
2017-04-11
First Post:
2006-07-31
Brief Title:
Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis Extension of Study P04271 NCT00251641 P04563
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2009-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-31
First Submit QC Date:
July 31 2006
Study First Post Date:
2006-08-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-11-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-13
Last Update Post Date:
2017-04-11
Last Update Post Date Type:
ACTUAL